Latest Period
Q2 2026
Security Snapshot
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG) Institutional Ownership
CUSIP: 88025U109
13F Institutional Holders and Ownership History from Q3 2019 to Q2 2026
Institutions Reporting
389
Shares (Excl. Options)
128,447,239
Price
$38.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Symbol
- TXG on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 128,447,239
- Total 13F value
- $4,913,346,359
- Portfolio coverage rank
- 0.01%
- Share change
- +3,485,403
- Value change
- +$186,158,100
- Number of holders
- 389
- Shares outstanding
- 116,858,154
- SEC-reported price per share
- $47.05
- Insider filing price
- $47.05
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share is tracked under CUSIP 88025U109.
- 389 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 329 to 389 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,657,017,234 to $4,913,346,359.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 389 institutions filings for Q2 2026.
Security key
88025U109
Latest holder period
Q2 2026
13F holders
389
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
TXG full holder history
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
10x Genomics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88025U109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
TXG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 16% | +44% | $355,109,205 | +$111,975,948 | 18,543,562 | +46% | FMR LLC | 27 Feb 2026 |
| VANGUARD GROUP INC | 12% | $155,176,941 | 13,274,332 | The Vanguard Group | 30 Sep 2025 | |||
| ARK Investment Management LLC | 8.6% | -18% | $383,517,244 | -$72,245,519 | 10,003,058 | -16% | ARK Investment Management LLC | 30 Jun 2026 |
| BlackRock, Inc. | 7.6% | $98,391,045 | 8,496,636 | BlackRock, Inc. | 30 Jun 2025 | |||
| Sumitomo Mitsui Trust Group, Inc. | 4.7% | -14% | $62,906,450 | -$7,397,081 | 5,381,219 | -11% | Sumitomo Mitsui Trust Group, Inc. | 30 Sep 2025 |
| Amova Asset Management Americas, Inc. | 4.7% | -14% | $62,855,762 | -$7,397,081 | 5,376,883 | -11% | Amova Asset Management Americas, Inc. | 30 Sep 2025 |
| MILLENNIUM MANAGEMENT LLC | 2.7% | -48% | $36,913,960 | -$29,821,474 | 3,060,859 | -45% | Millennium Management LLC | 30 Jun 2025 |
As of 30 Jun 2026, 389 institutional investors reported holding 128,447,239 shares of 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG). This represents 110% of the company’s total 116,858,154 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
86%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 17,629,266 | -0.63% | 0.03% | $675,906,044 |
| BlackRock, Inc. | 9.2% | 10,804,070 | +7.2% | 0.01% | $414,228,044 |
| ARK Investment Management LLC | 8.6% | 10,003,057 | -15% | 2.5% | $383,517,223 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6% | 6,982,492 | +1% | 0.01% | $267,708,743 |
| Quantinno Capital Management LP | 4.7% | 5,469,698 | +1.1% | 0.25% | $209,708,221 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 5,082,594 | -3.5% | 0% | $194,866,654 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.9% | 4,539,007 | +2681% | 0.02% | $174,026,000 |
| Sumitomo Mitsui Trust Group, Inc. | 3.6% | 4,194,627 | -18% | 0.09% | $160,821,999 |
| Amova Asset Management Americas, Inc. | 3.6% | 4,192,517 | -18% | 2.1% | $160,741,102 |
| MORGAN STANLEY | 2.9% | 3,351,910 | +26% | 0.01% | $128,512,270 |
| GOLDMAN SACHS GROUP INC | 2.7% | 3,148,859 | -21% | 0.01% | $120,727,254 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 3,082,790 | +6.1% | 0.01% | $118,215,187 |
| STATE STREET CORP | 2.4% | 2,801,437 | +8.2% | 0% | $107,407,095 |
| CITADEL ADVISORS LLC | 2.4% | 2,779,213 | +274% | 0.06% | $106,555,026 |
| DIMENSIONAL FUND ADVISORS LP | 1.9% | 2,225,284 | +8.9% | 0.02% | $85,306,075 |
| AQR CAPITAL MANAGEMENT LLC | 1.7% | 2,026,464 | -20% | 0.03% | $74,695,463 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.7% | 2,019,883 | -12% | 0.28% | $77,442,314 |
| Point72 Asset Management, L.P. | 1.6% | 1,852,776 | 0.11% | $71,035,432 | |
| Capital World Investors | 1.3% | 1,493,031 | +2.8% | 0.01% | $57,242,809 |
| T. Rowe Price Investment Management, Inc. | 1.1% | 1,266,954 | -0.97% | 0.03% | $48,576,000 |
| NORTHERN TRUST CORP | 0.98% | 1,144,027 | +9.2% | 0.01% | $43,861,995 |
| Nuveen, LLC | 0.96% | 1,124,633 | +80% | 0.01% | $43,118,429 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.93% | 1,087,150 | -3.5% | 0.01% | $41,681,331 |
| Casdin Capital, LLC | 0.9% | 1,050,000 | -54% | 2% | $40,257,000 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.85% | 988,320 | +5.3% | 0.07% | $37,892,189 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
28
Latest
Q2 2026
Rows shown
1-25 of 28
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 128,447,239 | $4,913,346,359 | +$186,158,100 | $38.34 | 389 |
| 2026 Q1 | 125,259,197 | $2,657,017,234 | +$60,722,024 | $21.23 | 329 |
| 2025 Q4 | 123,358,875 | $2,012,782,154 | +$17,019,168 | $16.31 | 321 |
| 2025 Q3 | 122,930,411 | $1,437,019,448 | +$5,456,573 | $11.69 | 313 |
| 2025 Q2 | 122,631,794 | $1,420,549,489 | +$119,573,048 | $11.58 | 293 |
| 2025 Q1 | 113,813,127 | $993,375,835 | +$50,874,984 | $8.73 | 269 |
| 2024 Q4 | 104,507,907 | $1,500,773,196 | -$41,937,351 | $14.36 | 270 |
| 2024 Q3 | 104,345,431 | $2,355,358,198 | -$6,296,831 | $22.58 | 258 |
| 2024 Q2 | 105,353,108 | $2,048,895,776 | +$7,101,276 | $19.45 | 254 |
| 2024 Q1 | 102,897,655 | $3,861,610,085 | +$222,058,012 | $37.53 | 280 |
| 2023 Q4 | 95,956,168 | $5,370,151,466 | +$202,330,286 | $55.96 | 267 |
| 2023 Q3 | 90,883,461 | $3,748,861,587 | +$66,054,684 | $41.25 | 252 |
| 2023 Q2 | 89,127,845 | $4,977,465,562 | -$57,613,061 | $55.84 | 269 |
| 2023 Q1 | 90,187,979 | $5,027,414,812 | +$211,396,981 | $55.79 | 255 |
| 2022 Q4 | 87,545,856 | $3,190,400,302 | +$104,674,768 | $36.44 | 253 |
| 2022 Q3 | 86,068,255 | $2,449,753,227 | -$43,840,073 | $28.48 | 208 |
| 2022 Q2 | 86,085,516 | $3,909,380,180 | +$83,806,084 | $45.25 | 228 |
| 2022 Q1 | 82,769,403 | $6,293,794,627 | -$74,133,769 | $76.07 | 286 |
| 2021 Q4 | 79,764,587 | $11,861,468,865 | +$65,047,101 | $148.96 | 347 |
| 2021 Q3 | 78,759,967 | $11,461,957,413 | +$127,530,777 | $145.58 | 317 |
| 2021 Q2 | 77,884,791 | $15,246,137,868 | +$1,517,689,271 | $195.82 | 332 |
| 2021 Q1 | 70,505,001 | $12,760,866,584 | +$832,242,795 | $181.00 | 310 |
| 2020 Q4 | 66,229,914 | $9,377,686,882 | -$749,751,524 | $141.60 | 299 |
| 2020 Q3 | 69,088,795 | $8,545,655,879 | +$1,071,434,021 | $124.68 | 215 |
| 2020 Q2 | 61,004,107 | $5,448,595,110 | +$1,160,387,284 | $89.31 | 141 |